Work

Preclinical Sequence Optimization for $^{129}$Xe HyperCEST MRI Applications Using a Phantom Simulating In Vivo Relaxation Times

Year: 2026

Type: conference-paper

Abstract: The growing demand for non-gadolinium MRI contrast agents highlights the relevance of advancing xenon biosensor technologies. This in vitro phantom solution facilitates translation of ¹²⁹Xe HyperCEST toward clinical use by enabling efficient optimization of imaging protocols under controlled, reproducible conditions.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.20810598

Authors: Gerbeth, Hannah Louise, Bender, Leonard, Kempny, Luca, Lipka, Alexandra, Bayer, Viktoria, Lehr, Samuel, Schröder, Leif

Institutions: German Cancer Research Center, Heidelberg University, Deutsches Konsortium für Translationale Krebsforschung

Language: English

Topic: Atomic and Subatomic Physics Research

Subfield: Atomic and Molecular Physics, and Optics

Field: Physics and Astronomy

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7166521072

FWCI:

Cites:

Cited by:

Related to: 10